Basic cardiovascular research and its implications for the medicinal use of nicotine

Journal of the American College of Cardiology

Volumn 41, Issue 3, 2003, Pages 497-498

  Benowitz, Neal L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ANGIOGENESIS; APOPTOSIS; CARDIOTOXICITY; CARDIOVASCULAR SYSTEM; CHOLINERGIC SYSTEM; CIGARETTE SMOKING; DOSE RESPONSE; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; NOTE; PRIORITY JOURNAL; SMOKING CESSATION;

EID: 0037419854     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02819-X     Document Type: Editorial

References (18)

1. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988;319:1318-30.
2. Fattinger K, Verotta D, Benowitz NL. Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans. J Pharmacol Exp Ther 1997;281:1238-46.
3. Heeschen C, Weis M, Cooke JP. Nicotine promotes collateral growth. J Am Coll Cardiol 2003;41:489-96.
4. Heeschen C, Weis M, Aicher A, Dimmeler S, Cooke JP. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest 2002;110:527-36.
5. Heeschen C, Jang JJ, Weis M, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001;7:833-9.
6. Suzuki J, Bayna E, Dalle Molle E, Lew WYW. Nicotine inhibits cardiac apoptosis induced by lipopolysaccharide in rats. J Am Coll Cardiol 2003;41:482-8.
7. Chalon S, Moreno H, Benowitz NL, Hoffman BB, Blaschke TF. Nicotine impairs endothelium-dependent dilatation in human veins in vivo. Clin Pharmacol Ther 2000;67:391-7.
8. Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q. Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol 1993;22:1159-67.
9. Benowitz NL, Jacob P III, Yu L. Daily use of smokeless tobacco: systemic effects. Ann Intern Med 1989;111:112-6.
10. 2 and prostacyclin metabolites in young men. Circulation 1991;83:1698-704.
11. Huhtasaari F, Lundberg V, Eliasson M, Janlert U, Asplund K. Smokeless tobacco as a possible risk factor for myocardial infarction. A population-based study in middle-aged men. J Am Coll Cardiol 1999;34:1784-90.
12. Huhtasaari F, Asplund K, Lundberg V, Stegmayr B, Wester PO. Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? BMJ 1992;305:1252-6.
13. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996;335:1792-8.
14. Mahmarian JJ, Moye LA, Nasser GA, et al. Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol 1997;30:125-30.
15. Mayhan WG, Patel KP. Effect of nicotine on endothelium-dependent arteriolar dilatation in vivo. Am J Physiol 1997;272:H2337-42.
16. Eliasson B, Taskinen MR, Smith U. Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation 1996;94:878-81.
17. Hellerstein MK, Benowitz NL, Neese RA, et al. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest 1994;93:265-72.
18. Suskin N, Sheth T, Negassa A, Yusuf S. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J Am Coll Cardiol 2001;37:1677-82.